| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | — |
| R&D Expense | $11.5M | -15.1% |
| SG&A Expense | $13.7M | +14.6% |
| Operating Income | -$24.2M | +5.2% |
| Pre-tax Income | -$22.6M | +12.9% |
| Income Tax | $100K | — |
| Net Income | -$18.5M | +8.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.7M | +289.0% |
| Accounts Receivable | $62K | -39.2% |
| Current Assets | $38.1M | +257.6% |
| Total Assets | $38.3M | +247.3% |
| Current Liabilities | $5.2M | -51.1% |
| Total Liabilities | $24.0M | -18.9% |
| Stockholders' Equity | $12.2M | +149.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.3M | -32.6% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $0 | -100.0% |
| Financing Cash Flow | $52.6M | +338.5% |
| Free Cash Flow | -$25.3M | -32.6% |